Tumor Necrosis Factor Alpha Transcription in Macrophages Is Attenuated by an Autocrine Factor That Preferentially Induces NF-κB p50

ABSTRACT Macrophages are a major source of proinflammatory cytokines such as tumor necrosis factor alpha (TNF-α), which are expressed during conditions of inflammation, infection, or injury. We identified an activity secreted by a macrophage tumor cell line that negatively regulates bacterial lipopolysaccharide (LPS)-induced expression of TNF-α. This activity, termed TNF-α-inhibiting factor (TIF), suppressed the induction of TNF-α expression in macrophages, whereas induction of three other proinflammatory cytokines (interleukin-1β [IL-1β], IL-6, and monocyte chemoattractant protein 1) was accelerated or enhanced. A similar or identical inhibitory activity was secreted by IC-21 macrophages following LPS stimulation. Inhibition of TNF-α expression by macrophage conditioned medium was associated with selective induction of the NF-κB p50 subunit. Hyperinduction of p50 occurred with delayed kinetics in LPS-stimulated macrophages but not in fibroblasts. Overexpression of p50 blocked LPS-induced transcription from a TNF-α promoter reporter construct, showing that this transcription factor is an inhibitor of the TNF-α gene. Repression of the TNF-α promoter by TIF required a distal region that includes three NF-κB binding sites with preferential affinity for p50 homodimers. Thus, the selective repression of the TNF-α promoter by TIF may be explained by the specific binding of inhibitory p50 homodimers. We propose that TIF serves as a negative autocrine signal to attenuate TNF-α expression in activated macrophages. TIF is distinct from the known TNF-α-inhibiting factors IL-4, IL-10, and transforming growth factor β and may represent a novel cytokine.

[1]  J. Hamilton Colony stimulating factors, cytokines and monocyte-macrophages--some controversies. , 1993, Immunology today.

[2]  S. Akira,et al.  Interleukin-6 in biology and medicine. , 1993, Advances in immunology.

[3]  D. Crothers,et al.  Equilibria and kinetics of lac repressor-operator interactions by polyacrylamide gel electrophoresis. , 1981, Nucleic acids research.

[4]  Y. Ohmori,et al.  Kappa B binding activity in a murine macrophage-like cell line. Sequence-specific differences in kappa B binding and transcriptional activation functions. , 1994, The Journal of biological chemistry.

[5]  M. Kirschner,et al.  Number and evolutionary conservation of α- and β-tubulin and cytoplasmic β- and γ-actin genes using specific cloned cDNA probes , 1980, Cell.

[6]  N. Rice,et al.  In vivo control of NF-xB activation by IxBa , 2022 .

[7]  Robert E. Kingston (CsCl isolation),et al.  Guanidinium Methods for Total RNA Preparation , 1991, Current protocols in molecular biology.

[8]  D. Gemsa,et al.  Release of tumor necrosis factor-alpha from macrophages. Enhancement and suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides. , 1988, Journal of immunology.

[9]  D. Ferrari,et al.  Activation of microglial cells by β-amyloid protein and interferon-γ , 1995, Nature.

[10]  M. Brown,et al.  Two forms of NF-kappa B1 (p105/p50) in murine macrophages: differential regulation by lipopolysaccharide, interleukin-2, and interferon-gamma. , 1997, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[11]  N. Mackman,et al.  Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors. , 1997, The Journal of biological chemistry.

[12]  A. Demus,et al.  Antibody-dependent cytolysis of chicken erythrocytes by an in vitro-established line of mouse peritoneal macrophages. , 1975, Journal of immunology.

[13]  A. Schattner,et al.  Lymphokines in autoimmunity--a critical review. , 1994, Clinical immunology and immunopathology.

[14]  I. Udalova,et al.  Conserved kappa B element located downstream of the tumor necrosis factor alpha gene: distinct NF-kappa B binding pattern and enhancer activity in LPS activated murine macrophages. , 1995, Oncogene.

[15]  C G Figdor,et al.  Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes , 1991, The Journal of experimental medicine.

[16]  M. Billah,et al.  Interleukin-10 inhibits interleukin-8 production in human neutrophils. , 1994, Blood.

[17]  W. Fiers,et al.  Molecular mechanisms of tumor necrosis factor‐induced cytotoxicity , 1994, FEBS letters.

[18]  H. Shepard,et al.  Inhibition of cytokine production by cyclosporin A and transforming growth factor beta , 1987, The Journal of experimental medicine.

[19]  R. Geha,et al.  Transcriptional activation of the human TNF-alpha promoter by superantigen in human monocytic cells: role of NF-kappa B. , 1995, Journal of immunology.

[20]  R. Stone Search for sepsis drugs goes on despite past failures. , 1994, Science.

[21]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[22]  I. Otterness,et al.  Regulation of monokine gene expression: prostaglandin E2 suppresses tumor necrosis factor but not interleukin-1 alpha or beta-mRNA and cell-associated bioactivity. , 1989, Journal of Leukocyte Biology.

[23]  H. Ziegler-Heitbrock,et al.  Interleukin-10 is upregulated in LPS tolerance. , 1995, Journal of inflammation.

[24]  C. Jongeneel,et al.  Enhancers and transcription factors controlling the inducibility of the tumor necrosis factor-alpha promoter in primary macrophages. , 1991, Journal of immunology.

[25]  Shakhov,et al.  KBTYPE ENHANCERS ARE INVOLVED IN LIPOPOLYSACCHARIDE-MEDIATED TRANSCRIPTIONAL ACTIVATION OF THE TUMOR NECROSIS FACTOR a GENE IN PRIMARY MACROPHAGES BY , 1990 .

[26]  Y. Vodovotz,et al.  Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10. , 1992, The Journal of biological chemistry.

[27]  I. Otterness,et al.  Regulation of Monokine Gene Expression: Prostaglandin E2 Suppresses Tumor Necrosis Factor but Not Interleukin‐1α or β‐mRNA and Cell‐Associated Bioactivity , 1989 .

[28]  A. Israël,et al.  The precursor of NF-κB p50 has IκB-like functions , 1992, Cell.

[29]  D. Hume,et al.  Endotoxin signal transduction in macrophages , 1996, Journal of leukocyte biology.

[30]  C. Rosen,et al.  Lipopolysaccharide induction of tissue factor gene expression in monocytic cells is mediated by binding of c-Rel/p65 heterodimers to a kappa B-like site , 1994, Molecular and cellular biology.

[31]  H. Ziegler-Heitbrock Molecular mechanism in tolerance to lipopolysaccharide. , 1995, Journal of inflammation.

[32]  D. Radzioch,et al.  Heterogeneity of hematopoietic cells immortalized by v-myc/v-raf recombinant retrovirus infection of bone marrow or fetal liver. , 1989, Journal of the National Cancer Institute.

[33]  T. Shinoda,et al.  Regulation of NFKB1 proteins by the candidate oncoprotein BCL‐3: generation of NF‐κB homodimers from the cytoplasmic pool of p50–p105 and nuclear translocation , 1997, The EMBO journal.

[34]  S. Akira,et al.  A nuclear factor for IL‐6 expression (NF‐IL6) is a member of a C/EBP family. , 1990, The EMBO journal.

[35]  P. Baeuerle,et al.  The p65 subunit is responsible for the strong transcription activating potential of NF‐kappa B. , 1991, The EMBO journal.

[36]  S. Nedospasov,et al.  KB Binding Activity in a Murine Macrophage-like Cell Line , 1994 .

[37]  Jun Ma,et al.  An HMG-like protein that can switch a transcriptional activator to a repressor , 1994, Nature.

[38]  A. Israël,et al.  The DNA binding subunit of NF-κB is identical to factor KBF1 and homologous to the rel oncogene product , 1990, Cell.

[39]  N. Mackman,et al.  Lipopolysaccharide Induction of the Tumor Necrosis Factor-α Promoter in Human Monocytic Cells , 1997, The Journal of Biological Chemistry.

[40]  M. Grilli,et al.  NF-kappa B subunit regulation in nontransformed CD4+ T lymphocytes. , 1992, Science.

[41]  C. Kunsch NF-idBSubunit-Specific Regulation ofthe Interleukin-8 Promoter , 1993 .

[42]  M. M. Garner,et al.  A gel electrophoresis method for quantifying the binding of proteins to specific DNA regions: application to components of the Escherichia coli lactose operon regulatory system , 1981, Nucleic Acids Res..

[43]  W. D. Fairlie,et al.  MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[44]  T. Mosmann,et al.  IL-10 inhibits cytokine production by activated macrophages. , 1991, Journal of immunology.

[45]  David Baltimore,et al.  Multiple nuclear factors interact with the immunoglobulin enhancer sequences , 1986, Cell.

[46]  C. Rosen,et al.  NF-kappa B subunit-specific regulation of the interleukin-8 promoter , 1993, Molecular and cellular biology.

[47]  K. Tracey,et al.  Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. , 1994, Annual review of medicine.

[48]  C V Jongeneel,et al.  Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages , 1990, The Journal of experimental medicine.

[49]  H. Ledebur,et al.  Transcriptional Regulation of the Intercellular Adhesion Molecule-1 Gene by Inflammatory Cytokines in Human Endothelial Cells , 1995, The Journal of Biological Chemistry.

[50]  R. Strieter,et al.  Dynamics of dibutyryl cyclic AMP- and prostaglandin E2-mediated suppression of lipopolysaccharide-induced tumor necrosis factor alpha gene expression , 1989, Infection and immunity.

[51]  M. Baer,et al.  Autocrine signals control CCAAT/enhancer binding protein beta expression, localization, and activity in macrophages. , 1998, Blood.

[52]  J. Haas,et al.  Tolerance to lipopolysaccharide involves mobilization of nuclear factor kappa B with predominance of p50 homodimers. , 1994, The Journal of biological chemistry.

[53]  H. Fahmi,et al.  Selective refractoriness of macrophages to endotoxin‐induced production of tumor necrosis factor, elicited by an autocrine mechanism , 1993, Journal of leukocyte biology.

[54]  M. Baer,et al.  C/EBP-related protein 2 confers lipopolysaccharide-inducible expression of interleukin 6 and monocyte chemoattractant protein 1 to a lymphoblastic cell line. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[55]  B. Beutler,et al.  Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[56]  N. Rice,et al.  In vivo control of NF‐kappa B activation by I kappa B alpha. , 1993, The EMBO journal.

[57]  P. Hart,et al.  Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[58]  G. Grimber,et al.  A beta-galactosidase hybrid protein targeted to nuclei as a marker for developmental studies. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[59]  M. Billah,et al.  IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. , 1994, Journal of immunology.

[60]  S. Nordeen,et al.  Luciferase reporter gene vectors for analysis of promoters and enhancers. , 1988, BioTechniques.

[61]  S. Ruben,et al.  Selection of optimal kappa B/Rel DNA-binding motifs: interaction of both subunits of NF-kappa B with DNA is required for transcriptional activation , 1992, Molecular and cellular biology.

[62]  U. Pauli,et al.  Control of tumor necrosis factor gene expression. , 1994, Critical reviews in eukaryotic gene expression.